ISPOR - PCN178 Cost-Effectiveness Analysis of Olaparib and Novel Hormonal Therapies in Metastatic Castration Resistant Prostate Cancer

Full Text

PCN178 Cost-Effectiveness Analysis of Olaparib and Novel Hormonal Therapies in Metastatic Castration Resistant Prostate Cancer

Abstract

Authors

G. Ko R. Hansen

Back to Volume 24, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now